Cargando…
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
Casitas B-lineage lymphoma (Cbl) family proteins are evolutionarily-conserved attenuators of protein tyrosine kinase (PTK) signaling. Biochemical analyses over the past two decades have firmly established that the negative regulatory functions of Cbl proteins are mediated through their ability to fa...
Autores principales: | Naramura, Mayumi, Nadeau, Scott, Mohapatra, Bhopal, Ahmad, Gulzar, Mukhopadhyay, Chandrani, Sattler, Martin, Raja, Srikumar M, Natarajan, Amarnath, Band, Vimla, Band, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134300/ https://www.ncbi.nlm.nih.gov/pubmed/21422499 |
Ejemplares similares
-
VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease
por: An, Wei, et al.
Publicado: (2016) -
Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation
por: Mukhopadhyay, Chandrani, et al.
Publicado: (2013) -
Negative Regulation of EGFR-Vav2 Signaling Axis by Cbl Ubiquitin Ligase Controls EGF Receptor-mediated Epithelial Cell Adherens Junction Dynamics and Cell Migration
por: Duan, Lei, et al.
Publicado: (2011) -
A novel CBL-B(flox/flox) mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells
por: Goetz, Benjamin, et al.
Publicado: (2016) -
Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy
por: An, Wei, et al.
Publicado: (2015)